FTT 0.00% 0.5¢ factor therapeutics limited

run coming?, page-56

  1. 9,595 Posts.
    lightbulb Created with Sketch. 330
    A pdf for the benchmark trial is downloadable from this page:

    https://www.researchgate.net/public...asound_in_the_management_of_venous_leg_ulcers

    I have had a good read through it and see no two week screening like our trial.

    So as you state Werble, the placebo in our trial (which is what our drug will be compared against) is likely to have a much lower healing rate than the benchmark study quoted in the presentation - as those easy healers were screened out.

    So the trial results could be pretty fantastic!

    Cross those fingers!

    ps. bare in mind that the benchmark quoted is a subset from the VenUS iii trial
    Last edited by supertramp: 25/05/18
 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.